Accel Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-16
Closed -$1.86K 355
2023
Q1
$1.86K Hold
16
﹤0.01% 1110
2022
Q4
$1.81K Hold
16
﹤0.01% 916
2022
Q3
$1K Hold
16
﹤0.01% 986
2022
Q2
$1K Buy
+16
New +$1.46K ﹤0.01% 946

Other funds holding DXCM

Accel Wealth Management's DXCM Position: Q2 2023 in Review

Accel Wealth Management sold out of DexCom (DXCM) in Q2 2023, closing a stake of 16 shares — an estimated $1.86K sold.

Accel Wealth Management first reported a position in DXCM in Q2 2022 and held it in 4 quarters. The position peaked at $1.86K in Q1 2023. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

  • Accel Wealth Management reported no remaining DexCom position as of Q2 2023 after selling out during the quarter.
  • Accel Wealth Management sold 16 DexCom shares in Q2 2023, an estimated $1.86K.
  • Accel Wealth Management first reported a position in DexCom in Q2 2022 and held it in 4 quarters.
  • Accel Wealth Management's DexCom position peaked at $1.86K in Q1 2023.
  • 954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on Accel Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.